Cargando…

Progressive resistance training in head and neck cancer patients during concomitant chemoradiotherapy -- design of the DAHANCA 31 randomized trial

BACKGROUND: Head and neck cancer patients undergoing concomitant chemoradiotherapy (CCRT) frequently experience loss of muscle mass and reduced functional performance. Positive effects of exercise training are reported for many cancer types but biological mechanisms need further elucidation. This ra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lonkvist, Camilla K., Lønbro, Simon, Vinther, Anders, Zerahn, Bo, Rosenbom, Eva, Primdahl, Hanne, Hojman, Pernille, Gehl, Julie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457597/ https://www.ncbi.nlm.nih.gov/pubmed/28578654 http://dx.doi.org/10.1186/s12885-017-3388-0

Ejemplares similares

Progressive resistance training in head and neck cancer patients undergoing concomitant chemoradiotherapy
por: Lonkvist, Camilla K., et al.
Publicado: (2017)

Collagen fragment biomarkers as serological biomarkers of lean body mass – a biomarker pilot study from the DAHANCA25B cohort and matched controls
por: Nedergaard, Anders, et al.
Publicado: (2015)

Voluntary Exercise Prevents Cisplatin-Induced Muscle Wasting during Chemotherapy in Mice
por: Hojman, Pernille, et al.
Publicado: (2014)

Erythropoietin Over-Expression Protects against Diet-Induced Obesity in Mice through Increased Fat Oxidation in Muscles
por: Hojman, Pernille, et al.
Publicado: (2009)

Exercise-Mediated Lowering of Glutamine Availability Suppresses Tumor Growth and Attenuates Muscle Wasting
por: Pedersen, Katrine S., et al.
Publicado: (2020)

Comparison of vinorelbine with cisplatin in concomitant chemoradiotherapy in head and neck carcinoma
por: Devleena,, et al.
Publicado: (2010)

Gene expression profiles in skeletal muscle after gene electrotransfer
por: Hojman, Pernille, et al.
Publicado: (2007)

Change in Hemoglobin Levels due to Anesthesia in Mice: An Important Confounder in Studies on Hematopoietic Drugs
por: Gothelf, Anita, et al.
Publicado: (2009)

In Vivo Imaging of Far-red Fluorescent Proteins after DNA Electrotransfer to Muscle Tissue
por: Hojman, Pernille, et al.
Publicado: (2009)

Epidemiology, outcomes, and prognostic factors in submandibular gland carcinomas: a national DAHANCA study
por: Westergaard-Nielsen, Marie, et al.
Publicado: (2023)

Calcium Electroporation for Management of Cutaneous Metastases in HER2-Positive Breast Cancer: A Case Report
por: Jensen, Katrine Borres, et al.
Publicado: (2022)

Electroporation Enhanced Effect of Dystrophin Splice Switching PNA Oligomers in Normal and Dystrophic Muscle
por: Brolin, Camilla, et al.
Publicado: (2015)

Chemoradiotherapy for Head and Neck Cancer
por: D’Onofrio, Ida, et al.
Publicado: (2023)

Comparison of Carboplatin With 5-Fluorouracil vs. Cisplatin as Concomitant Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
por: Hanemaaijer, Saskia H., et al.
Publicado: (2020)

Chemoradiotherapy With Generic Cisplatin Formulations for Head and Neck Cancers
por: Shimada, Rie, et al.
Publicado: (2018)

Prognostic Role of Diffusion Weighted and Dynamic Contrast-enhanced MRI in Loco-regionally Advanced Head and Neck Cancer Treated with Concomitant Chemoradiotherapy
por: Garbajs, Manca, et al.
Publicado: (2019)

Chemoradiotherapy as Definitive Treatment for Elderly Patients with Head and Neck Cancer
por: Müller von der Grün, Jens, et al.
Publicado: (2018)

Current Omics Trends in Personalised Head and Neck Cancer Chemoradiotherapy
por: Marcu, Loredana G., et al.
Publicado: (2021)

Weight Loss in Post-Chemoradiotherapy Head and Neck Cancer Patients
por: Abu Zaid, Zalina, et al.
Publicado: (2022)

A Prospective, Longitudinal and Exploratory Study of Head and Neck Lymphoedema and Dysphagia Following Chemoradiotherapy for Head and Neck Cancer
por: Jeans, Claire, et al.
Publicado: (2022)

The Nephroprotective Effect of Mannitol in Head and Neck Cancer Patients Receiving Cisplatin Therapy
por: Hägerström, Erik, et al.
Publicado: (2019)

Caregivers’ burden and fatigue during and after patients’ treatment with concomitant chemoradiotherapy for locally advanced head and neck cancer: a prospective, observational pilot study
por: Langenberg, Simone M. C. H., et al.
Publicado: (2019)

Change of Swallowing in Patients With Head and Neck Cancer After Concurrent Chemoradiotherapy
por: Kweon, Sehi, et al.
Publicado: (2016)

A preliminary Study on the Effect of Head and Neck Chemoradiotherapy on Systematic Immunity
por: Huang, Weiqiang, et al.
Publicado: (2019)

Nutritional interventions in patients with head and neck cancer undergoing chemoradiotherapy: Current practice at the Dutch Head and Neck Oncology centres
por: Kok, Annemieke, et al.
Publicado: (2021)

Exercise suppresses tumor growth independent of high fat food intake and associated immune dysfunction
por: Hojman, Pernille, et al.
Publicado: (2022)

Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial
por: Tobias, Jeffrey S, et al.
Publicado: (2009)

Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer
por: Balermpas, P, et al.
Publicado: (2014)

Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer
por: Balermpas, P, et al.
Publicado: (2014)

Combined Nimotuzumab with Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
por: Thai Hoa, Nguyen Thi, et al.
Publicado: (2020)

Impact of Diabetes Mellitus on Head and Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy
por: Kuo, Hsuan-Chih, et al.
Publicado: (2020)

Clinical Impact of Cachexia in Head and Neck Cancer Patients Who Received Chemoradiotherapy
por: Hayashi, Naomi, et al.
Publicado: (2021)

Calcium electroporation for recurrent head and neck cancer: A clinical phase I study
por: Plaschke, Christina Caroline, et al.
Publicado: (2019)

Current role of human papillomavirus in head and neck oncology
por: Lassen, Pernille
Publicado: (2013)

Nutritional Interventions in Head and Neck Cancer Patients Undergoing Chemoradiotherapy: A Narrative Review
por: Bossola, Maurizio
Publicado: (2015)

The provision of enteral nutritional support during definitive chemoradiotherapy in head and neck cancer patients
por: Bishop, Sarah, et al.
Publicado: (2015)

Leukocytosis, prognosis biomarker in locally advanced head and neck cancer patients after chemoradiotherapy
por: Schernberg, Antoine, et al.
Publicado: (2018)

T cell abundance in blood predicts acute organ toxicity in chemoradiotherapy for head and neck cancer
por: Beschel, L. Milena, et al.
Publicado: (2016)

Immune Check-Point Inhibitors and Standard Chemoradiotherapy in Definitive Head and Neck Cancer Treatment
por: De Felice, Francesca, et al.
Publicado: (2021)

Trismus Occurrence and Link With Radiotherapy Doses in Head and Neck Cancer Patients Treated With Chemoradiotherapy
por: Faravel, Kerstin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0i0ev78g3vbq9cvoaeuiilmnmd